Therapeutic Action And Extrapyramidal Side Effects Of The First Generation Antipsychotic Agents

812 Words Jan 2nd, 2016 4 Pages
The therapeutic action and extrapyramidal side effects of the first generation antipsychotic agents are effected through blocking of the brain receptors in the nigrostriatal and mesolimbocortical areas as well as subtype 2 (D2) and dopamine (Swerdlow, 2010),. Scientific evidence provides support for the argument that schizophrenia in its acute phase can be effectively controlled by the first generation antipsychotic medications. These medications would be ideal for both the negative and positive symptoms of schizophrenic psychosis. The negative symptoms here include avolition, alogia, affective blunting and apathy. The positive ones are bizarre behaviors, delusions and hallucinations. The efficacy of the medications in the stable phases and stabilization in general is not fully guaranteed. Their use in this phase is instead entirely based on the fact that most patients would experience a relapse of the disorder in case treatment is discontinued (Bellack, 2013).
Another way of treating schizophrenia is through psychosocial treatments. Rubin, Springer & Trawver (2011) note that schizophrenic individuals who have already undergone antipsychotic medication and are of a stable condition would find psychosocial treatments helpful. Through such treatments, they would be in a position to cope with the challenges presented by the disorder on a daily basis. Some of the challenges in this regard include formation and maintenance of relationships, self-care difficulties and…

Related Documents